Log In
BCIQ
Print this Print this
 

CSL324

  Manage Alerts
Collapse Summary General Information
Company CSL Ltd.
DescriptionRecombinant mAb against the cytokine granulocyte colony stimulating factor receptor (G-CSFR)
Molecular Target Granulocyte colony-stimulating factor (G-CSF) (CSF3)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today